Real-world evidence demonstrates efficacy of HPV vaccine Zero cases of cervical cancer have been detected in Scotland among those who received the bivalent vaccine by age 12.
RSV vaccine approved by TGA AREXVY will soon be available for patients aged 60 and over, sparking hope it will ease the pressure on Australia’s overflowing hospitals.
Genetic link to asymptomatic COVID: Study Landmark research finds gene variants and exposure to the common cold could help develop more impactful COVID-19 medications.
‘Catch up’ HPV test may benefit older women New research suggests screening women aged 65 and over who have never been tested for HPV could improve cervical cancer prevention.
Massive growth in use of cervical self-collection screening Use of the screening option has at least doubled in each quarter since eligibility expanded, MBS statistics show.
Possible RSV vaccine is ‘very exciting’ Given to pregnant women, the RSV vaccine is shown to prevent severe disease for up to the first six months of life.
Changes made to COVID Vaccine Claims Scheme The Department of Health and Aged Care has removed and added certain conditions that can be claimed in relation to COVID vaccine adverse reactions.
In Practice: Telehealth exemptions for PCR tests extended Patients who meet the COVID ‘high-risk’ criteria have had the telehealth temporary exemption rule extended to 31 December.
How collaboration can help counteract vaccine fatigue A program aimed at boosting COVID vaccination among vulnerable populations highlights the role of GP-led teams, writes Dr Ken McCroary.
Children’s version of COVID vaccination calculator released While vaccine coverage for 5–11-year-olds remains low, the updated CoRiCal tool could help boost uptake among the cohort.